Free Trial

Entasis Therapeutics (ETTX) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Short Interest in Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Decreases By 35.4%
Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX - Get Rating) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 105,100 shares, a decline of 35.4% from the April 30th total of 162,700 shares. Based on an average daily trading volume, of 169,900 shares, the short-interest ratio is presently 0.6 days. Currently, 0.7% of the company's shares are short sold.
Entasis Flat on Data
Entasis Therapeutics (NASDAQ:ETTX) Downgraded by Alliance Global Partners to Neutral
Alliance Global Partners downgraded Entasis Therapeutics from a "buy" rating to a "neutral" rating in a report on Wednesday.
Entasis Therapeutics (NASDAQ:ETTX) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research raised Entasis Therapeutics from a "hold" rating to a "buy" rating and set a $2.00 target price on the stock in a research report on Tuesday.
Entasis gains on buyout proposal from Innoviva
Moderna Highlights New Clinical Data on its COVID-19 Vaccine
Get Entasis Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETTX and its competitors with MarketBeat's FREE daily newsletter.

Does this make you sick? (Ad)

The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.

Get your Free Wealth Protection Kit

ETTX Media Mentions By Week

ETTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ETTX
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

ETTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ETTX Articles
This Week

0

0

ETTX Articles
Average Week

Get Entasis Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ETTX) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners